Dudediligence.

Thermo Fisher Scientific Inc

TMONYSE · Measuring & Controlling Devices, NEC
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$10.60BSep ’24$11.39BDec ’24$10.36BMar ’25$10.86BJun ’25$11.12BSep ’25$12.21BDec ’25$11.01BMar ’26$11.99BJun ’26
Net income, by quarter
$1.63BSep ’24$1.83BDec ’24$1.51BMar ’25$1.62BJun ’25$1.62BSep ’25$1.98BDec ’25$1.65BMar ’26$1.74BJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$39.21B$44.91B$42.86B$42.88B$44.56B
Operating income$10.03B$8.39B$6.86B$7.34B$7.75B
Net income$7.73B$6.96B$6.00B$6.33B$6.72B
Operating cash flow$9.31B$9.15B$8.41B$8.67B$7.82B
Free cash flow$6.79B$6.91B$6.93B$7.27B$6.29B
Cash$4.48B$8.52B$8.08B$4.01B$9.85B
Debt$34.87B$34.49B$34.92B$31.27B$42.70B
Shares outstanding439.2M440.7M442.2M443.8M445.2M
TMO fundamentals · DudeDiligence